These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23769340)

  • 1. [Interpretation of IASLC/ATS/ERS international multidisciplinary classification of lung neoplasms].
    Lin D
    Zhongguo Fei Ai Za Zhi; 2013 Jun; 16(6):277-81. PubMed ID: 23769340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comments on International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma (2011)].
    Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):793-6. PubMed ID: 22336202
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
    Rodriguez EF; Monaco SE; Dacic S
    Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The international multidisciplinary classification of lung adenocarcinoma from IASLC/ATS/ERS and problems in clinical practice].
    Yan L; Yi X
    Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):333-8. PubMed ID: 23866662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsolid pulmonary nodules: CT-pathologic correlation using the 2011 IASLC/ATS/ERS classification.
    Liao JH; Amin VB; Kadoch MA; Beasley MB; Jacobi AH
    Clin Imaging; 2015; 39(3):344-51. PubMed ID: 25709110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Small biopsies and cytologic specimens management in microscopic diagnosis and subtyping of non-small cell lung cancer, as recommended by IASLC/ATS/ERS].
    Langfort R; Szołkowska M; Szczepulska-Wójcik E; Maksymiuk B
    Pneumonol Alergol Pol; 2012; 80(2):172-7. PubMed ID: 22370987
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.
    Yang SM; Chen LW; Wang HJ; Chen LR; Lor KL; Chen YC; Lin MW; Hsieh MS; Chen JS; Chang YC; Chen CM
    Lung Cancer; 2018 May; 119():56-63. PubMed ID: 29656753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
    Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
    Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IASLC/ATS/ERS international multidisciplinary new classification of lung adenocarcinoma and its clinical significance].
    Feng RE
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):95-6. PubMed ID: 22455963
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
    Villa C; Cagle PT; Johnson M; Patel JD; Yeldandi AV; Raj R; DeCamp MM; Raparia K
    Arch Pathol Lab Med; 2014 Oct; 138(10):1353-7. PubMed ID: 24571650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
    Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.
    Sun Y; Hou L; Yang Y; Xie H; Yang Y; Li Z; Zhao H; Gao W; Su B
    Onco Targets Ther; 2016; 9():4583-91. PubMed ID: 27524912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.
    Duhig EE; Dettrick A; Godbolt DB; Pauli J; van Zwieten A; Hansen AR; Yang IA; Fong KM; Clarke BE; Bowman RV
    J Thorac Oncol; 2015 Apr; 10(4):673-81. PubMed ID: 25514800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.
    Wang H; Zhang W; Wang K; Li X
    Medicine (Baltimore); 2018 Jun; 97(26):e11116. PubMed ID: 29952952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.